Dr. Fauci: New, government-wide Pandemic Preparedness Plan upgrades existing NIAID plans - Government Matters

Published 11:01 AM, February 13, 2022

A new Pandemic Preparedness Plan from the National Institute of Allergy and Infectious Diseases (NIAID) in the National Institutes of Health (NIH) paves the way for faster responses to emerging or re-emerging threats of infectious diseases.

  • Dr. Anthony Fauci, director of NIAID and chief medical advisor to the president, said the new plan is government-wide and upgrades plans for emerging and re-emerging infectious diseases that NIAID has had in place for years.
  • The plan includes identifying priority pathogens and prototype pathogens. Fauci explained that priority pathogens are very specific microbes that scientists suspect could evolve into a pandemic form, whereas prototype pathogens are broad virus families, like coronaviruses, that are important to prepare for in case one of the viruses becomes a threat.
  • Fauci said this strategy has been "extraordinarily successful" in the past, with coronavirus research starting before 2002 that ultimately led to the development of the Covid-19 vaccine.
  • The plan involves an all-of-government response, said Fauci, with coordination between the Department of Health and Human Services (HHS), the Defense Department (DoD), the United States Agency for International Development (USAID), the State Department and others.
  • Fauci said NIAID scientists work on research for vaccines and treatments, provide grants to universities and medical centers and collaborate with pharmaceutical companies.
  • He said NIH has a strong communication enterprise, working with a White House communications group several times a week and one at HHS daily.
  • Work on a pan-coronavirus vaccine, advanced diagnostics and antiviral discovery and development are going on now in preparation for future outbreaks, Fauci said.

Comments

Post a Comment

Popular posts from this blog

How to Deal with Vaginal Infections and Vaginal Atrophy After Menopause

Image
cvs brand monistat :: Article Creator CVS Health Corp Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor's point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research. Read our editorial policy to learn more about our process. The Most Trusted Brands In The U.S. 2024 Midas Automotive Auto Brake Service
Read more

Needless treatments: anti-fungal creams or tablets don't always work for vaginal itch

Image
burning genital warts :: Article Creator How Can The Dental Team Prevent The Spread Of STIs? This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data. Cancer-predisposition Variants Associated With Adverse Outcomes In Rhabdomyosarcoma Germline cancer-predisposition variants (CPVs) can be helpful in predicting risk in some pediatric cancers. However, CPV risk association in children with rhabdomyosarcoma has not been well studied. A new report led by researchers at Baylor College of Medicine evaluates the association of germline CPVs with rhabdomyosarcoma outcomes in a cohort of children enrolled in Children's Oncology Group studies. The findings are published in JAMA
Read more